Thomas W. Dubensky
Signal active
President & CEO
Bio
Thomas W. Dubensky is the current President and CEO of ImmuneSensor Therapeutics. He previously worked at Theriva Biologics, Inc. as a Scientific Advisory Board Member. Thomas W. Dubensky attended the University of California, San Diego.
Location
Berkeley, California, United States, North America
Social
Primary Organization
Tempest Therapeutics
Founded
2011
Employees
11-50
Industry
Biotechnology, Health Care, Therapeutics
Jobs history
5
Remedy Plan Therapeutics
Scientific Advisory Board Member
2021 - Current
CMTA
Board Member
2016 - Current
ImmuneSensor Therapeutics
President & CEO
2024 - Current
Tempest Therapeutics
President & Founder
2021 - Invalid date
Tempest Therapeutics
CEO
2017 - Invalid date
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Thomas W. Dubensky is the President & CEO at Tempest Therapeutics, based in United States, North America. With a background in Biotechnology, Thomas W. Dubensky has a rich history of leadership and innovation. Thomas W. Dubensky studied Post Doctoral Viral Pathogenesis and Tumor Biology @ Harvard Medical School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
1
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Nov 16, 2023 | Armatus Bio | Seed Round - Armatus Bio | CMTA | 0 |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.